文献速递重症综合管理与镇静镇痛儿科与产科急症

体外膜氧合支持下儿童脑死亡的临床判定

Clinical Determination of Brain Death in Children Supported by Extracorporeal Membrane Oxygenation.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论在VA-ECMO支持的儿童中,通过调整ECMO回路(降低扫气流、加入二氧化碳、增加泵流量)可完成呼吸暂停试验,从而实现脑死亡的临床判定。

该单中心回顾性研究纳入2010至2018年间在VA-ECMO支持下接受脑死亡检查的8例儿科患者,共进行14次脑死亡检查(含呼吸暂停试验),其中6例达到脑死亡标准,2例在首次检查后撤除技术支持。多数呼吸暂停试验(13/14)通过调整ECMO回路实现高碳酸血症,同时维持氧合和血流动力学稳定:10次检查前降低扫气流,3次检查中向回路加入二氧化碳,2次检查中因低血压增加ECMO泵流量。结论认为,ECMO支持的儿科患者可进行包括呼吸暂停试验在内的脑死亡临床判定,且ECMO回路可有效调整以在呼吸暂停试验期间及时升高二氧化碳并维持稳定。

要点

  • 8例VA-ECMO支持的儿科患者共接受14次脑死亡检查,其中6例达到脑死亡标准。
  • 呼吸暂停试验期间通过降低扫气流(10次)、向回路加入二氧化碳(3次)或增加泵流量(2次)来调整ECMO回路。
  • 多数呼吸暂停试验(13/14)成功实现高碳酸血症,同时维持氧合和血流动力学稳定。
  • 2例患者在首次脑死亡检查后撤除技术支持。
  • 作者认为,ECMO支持的儿科患者可进行包括呼吸暂停试验在内的脑死亡临床判定。

适用人群与场景

  • 2010至2018年间在某单中心三级儿童医院接受VA-ECMO支持的儿科患者,因存在灾难性神经损伤风险而接受脑死亡检查。

处置流程与药物剂量

  • 呼吸暂停试验前降低ECMO扫气流(10次检查中采用)。
  • 呼吸暂停试验期间向ECMO回路加入二氧化碳(3次检查中采用)。
  • 呼吸暂停试验期间因低血压增加ECMO泵流量(2次检查中采用)。

研究设计与关键结果

  • 单中心回顾性研究,纳入8例VA-ECMO支持的儿科患者,共进行14次脑死亡检查(含呼吸暂停试验),其中6例达到脑死亡标准,2例在首次检查后撤除技术支持。
  • 13/14次呼吸暂停试验中,ECMO回路被调整以实现高碳酸血症,同时维持氧合和血流动力学稳定。

证据类型、等级与局限

  • 证据类型:单中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ECMO支持的儿科患者可进行包括呼吸暂停试验在内的脑死亡临床判定。
  • 作者认为,呼吸暂停试验期间可有效调整ECMO回路以在维持氧合和血流动力学稳定的同时及时升高二氧化碳。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVE: Children supported by extracorporeal membrane oxygenation (ECMO) are at risk of catastrophic neurologic injury and brain death. Timely determination of brain death is important for minimizing psychological distress for families, resource allocation, and organ donation. Reports of successful determination of brain death in pediatric patients supported by ECMO are limited. The determination of brain death by clinical criteria requires apnea testing, which has historically been viewed as challenging in patients supported by ECMO. We report eight pediatric patients who underwent a total of 14 brain death examinations, including apnea testing, while supported by veno-arterial ECMO (VA-ECMO), resulting in six cases of clinical determination of brain death.

METHODS: We performed a retrospective review of the medical records of pediatric patients who underwent brain death examination while supported by VA-ECMO between 2010 and 2018 at a single tertiary care children's hospital.

RESULTS: Eight patients underwent brain death examination, including apnea testing, while supported by VA-ECMO. Six patients met criteria for brain death, while two had withdrawal of technical support after the first examination. During the majority of apnea tests (n = 13/14), the ECMO circuit was modified to achieve hypercarbia while maintaining oxygenation and hemodynamic stability. The sweep flow was decreased prior to apnea testing in ten brain death examinations, carbon dioxide was added to the circuit during three examinations, and ECMO pump flows were increased in response to hypotension during two examinations.

CONCLUSIONS: Clinical determination of brain death, including apnea testing, can be performed in pediatric patients supported by ECMO. The ECMO circuit can be effectively modified during apnea testing to achieve a timely rise in carbon dioxide while maintaining oxygenation and hemodynamic stability.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Harrar DB, Kukreti V, Dean NP, et al. Clinical Determination of Brain Death in Children Supported by Extracorporeal Membrane Oxygenation. Neurocrit Care. 2019. PMID: 30891693. doi:10.1007/s12028-019-00700-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。